WEE1 and neoplasm: In contrast, the AZD1775 IC50 increased by approximately 4.5-fold in the tumor cells isolated from the AZD1775-treated cells compared with the treatment-naive tumor cells (Figure 1E), indicating the successful induction of resistance to WEE1 induction in vivo.